SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-134505
Filing Date
2009-06-22
Accepted
2009-06-22 09:02:46
Documents
7
Period of Report
2009-06-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 22673
2 AWARENESS LETTER OF DELOITTE & TOUCHE LLP dex15.htm EX-15 3328
3 CONSENT OF DELOITTE & TOUCHE LLP dex23.htm EX-23 2049
4 SCHERING-PLOUGH AUDITED HISTORICAL CONSOLIDATED FINANCIAL STATEMENTS dex991.htm EX-99.1 1003423
5 SCHERING-PLOUGH UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS dex992.htm EX-99.2 315820
6 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION dex993.htm EX-99.3 320028
7 RISK FACTORS dex994.htm EX-99.4 127876
  Complete submission text file 0001193125-09-134505.txt   1796727
Mailing Address ONE MERCK DR PO BOX 100 WS3AB-05 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DR P O BOX 100 WHITEHOUSE STATION NJ 08889-0100 9084231688
MERCK & CO INC (Filer) CIK: 0000064978 (see all company filings)

IRS No.: 221109110 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03305 | Film No.: 09902473
SIC: 2834 Pharmaceutical Preparations